INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/23/2026
Back to search
Official data from USPTO
REGENOKINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REGENOKINE
ST13
US500000079228346Class
5, 10, 44
Filing
79228346
Registration
5663524
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
02/24/2026
Trademark type
Word
Nice classes
5, 10, 44
Filing date
12/21/2017
Registration date
01/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2025
Last transaction
02/24/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Düsseldorf, DE
Examiner
COLEMAN, CIMMERIAN
Current location
Historical data usage
Holders and representatives
Holders
ORTHOGEN AG
ORTHOGEN AG
Representatives
Jillian M. Taylor Blank Rome LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical therapeutic remedy preparations for treating jointsmusclesnervesligamentscartilage and bones; medicated dermatological preparationsdermatological preparations for medical purposes
Class 10
Instrumentsequipment and apparatus for the removalprocessing and storage of blood or blood preparations in the medical sectorsyringesblood collection bagscannulae; medical instruments and apparatus and their systems for blood removal in particular of consisting of syringesblood collection bags and tubes; Syringesblood collection bagsblood collecting tubes for blood removal
Class 44
Medical and hygienic carein particular in the field of treating diseases of the locomotor systemthe nervous system and the immune system; providing medical testing and evaluation of DNA-based diagnostic tests for rheumatoid diseases and diseases of the locomotor system; medical treatment of diseases of the locomotor system and of the nervous system using cytokine and preparations containing cytokine
Publications
History of USPTO decisions and trademark events.
45 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/23/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
06/23/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/12/2025
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
05/29/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/28/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
12/18/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/29/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/14/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/14/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/07/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/22/2019
FIMP
FINAL DISPOSITION PROCESSED
05/21/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/29/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
GPNX
NOTIFICATION PROCESSED BY IB
11/09/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/24/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/24/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2018
RFNT
REFUSAL PROCESSED BY IB
05/04/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/16/2018
RFRR
REFUSAL PROCESSED BY MPU
04/16/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/12/2018
CNRT
NON-FINAL ACTION WRITTEN
04/11/2018
DOCK
ASSIGNED TO EXAMINER
04/02/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/08/2018
Continuous trademark protection
Get notified about every new filing that threatens REGENOKINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.